SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
SEC Accession No. 0001178913-24-002671
Filing Date
2024-08-19
Accepted
2024-08-19 06:01:43
Documents
49
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 6-K/A zk2431880.htm   iXBRL 6-K/A 19939
2 EXHIBIT 99.1 exhibit_99-1.htm EX-99.1 130461
3 EXHIBIT 99.2 exhibit_99-2.htm   iXBRL EX-99.2 567329
4 GRAPHIC image0.jpg GRAPHIC 29809
5 GRAPHIC image1.jpg GRAPHIC 17571
  Complete submission text file 0001178913-24-002671.txt   3074845

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE slgl-20240630.xsd EX-101.SCH 36814
7 XBRL CALCULATION FILE slgl-20240630_cal.xml EX-101.CAL 27778
8 XBRL DEFINITION FILE slgl-20240630_def.xml EX-101.DEF 70768
9 XBRL LABEL FILE slgl-20240630_lab.xml EX-101.LAB 312961
10 XBRL PRESENTATION FILE slgl-20240630_pre.xml EX-101.PRE 142576
51 EXTRACTED XBRL INSTANCE DOCUMENT zk2431880_htm.xml XML 327289
Mailing Address 7 GOLDA MEIR ST. WEIZMANN SCIENCE PARK NESS ZIONA L3 7403648
Business Address 7 GOLDA MEIR ST. WEIZMANN SCIENCE PARK NESS ZIONA L3 7403648 97289313433
Sol-Gel Technologies Ltd. (Filer) CIK: 0001684693 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K/A | Act: 34 | File No.: 001-38367 | Film No.: 241218157
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)